Skip to content

A Clinical Trial to Evaluate the Safety and Effectiveness of Resorbable Collagen Membrane - MatrixflexTM

A Clinical Trial to Evaluate the Safety and Effectiveness of Resorbable Collagen Membrane - MatrixflexTM for the Treatment of Periodontal Intrabony Defects

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04851847
Enrollment
174
Registered
2021-04-21
Start date
2021-06-10
Completion date
2022-08-01
Last updated
2022-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Guided Tissue Regeneration, Intrabony Defects, Periodontal Diseases

Keywords

resorbable collagen membrane

Brief summary

This is a randomized, single blind, parallel-arm, multi-center, non-inferior clinical trial. 174 patients are recruited in total, and they are treated by Guided Tissue Regeneration (GTR). The patients are split in to two groups evenly: 87 in the experimental group and 87 in the control group.

Interventions

Use of resorbable collagen membrane to treat periodontal intrabony defects.

Sponsors

Collagen Matrix
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Aged 18 to 65 years, male or female; 2. patients were clinically diagnosed with chronic periodontitis according to the international classification of periodontal disease in 1999; 3. Only solitary lesion site requires surgical treatment and must meet the following criteria: 1. The baseline PD≥7 mm ; 2. After debridement during operation, the defect of the vertical bone at the adjacent surface ≥4mm, and at least one alveolar buccal wall can be detected; 3. The wideness of the keratinized gingiva≥2 mm; 4. Based on the X-Ray image, the dental crowns at the bottom of the bone socket should be at least 3mm;

Exclusion criteria

1. The test tooth has open surgical debridement history within the most recent one years; 2. Known allergy to collagen of animal origin; 3. Clinical or radiographic signs of untreated acute infection at the surgical site, apical pathology, root fracture, severe root irregularities, cemental pearls, cemento-enamel projections not easily removed by odontoplasty, untreated carious lesions at the cemento-enamel junction (CEJ) or on the root surface, subgingival restorations and/or restorations with open margins at or below the CEJ;

Design outcomes

Primary

MeasureTime frameDescription
The change of CAL at 12 weeks after surgery12 weeksAssessment of clinical attachment level
The change of CAL at 24 weeks after surgery24 weeksAssessment of clinical attachment level
The change of PD at 12 weeks after surgery12 weeksAssessment of Probing Depth
The change of PD at 24 weeks after surgery24 weeksAssessment of Probing Depth

Secondary

MeasureTime frameDescription
The ratio between Baseline and gingival recession (GR) at 12 weeks after surgery.12 weeksEffect on Gingival recession
The ratio between Baseline and gingival recession (GR) at 24 weeks after surgery.24 weeksEffect on Gingival recession

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026